期刊文献+

腺病毒转染血管内皮生长因子基因对感染大鼠骨髓间充质干细胞的影响

Effect of transfecting VEGF gene with AdCMV vector on rat bone marrow mesenchymal stem cells
原文传递
导出
摘要 目的体外观察和检测腺病毒AdCMV转染血管内皮生长因子(VEGF)基因对大鼠骨髓间充质干细胞(BMSCs)增殖的影响。方法培养大鼠BMSCs,用AdCMV-增强型绿色荧光蛋白(eGFP)、AdCMV-VEGF感染大鼠BMSCs,MTT检测AdCMV-VEGF对大鼠BMSCs增殖的影响,Western blot检测不同浓度的AdCMV-VEGF感染大鼠BMSCs后蛋白的表达量和BMSCs组、AdCMV-eGFP组、AdCMV-VEGF组细胞的VEGF蛋白表达量的差异。结果成功培养了BMSCs。与BMSCs组和AdCMV-eGFP组比较,AdCMV-VEGF组的VEGF蛋白表达较多。结论成功获得大鼠BMSCs,且AdCMV-VEGF成功转染大鼠BMSCs,为缺血性脑血管疾病治疗提供有用的参考。 Objective To study the effect of transfecting VEGF gene with AdCMV vector on rat bone marrow mesenchymal stem cells(BMSCs) in vitro. Methods The rat BMSCs were cultured in vitro and infected with AdCMV-eGFP and AdCMV-VEGF. The effect of transfecting VEGF on the proliferation of rat BMSCs was evaluated by MTT. The expression of VEGF gene in BMSCs transfected with different concentrations of AdCMV vector was detected by Western blot. The difference of VEGF gene expression among groups of AdCMV-eGFP, AdCMV-VEGF and untransfected cells were detected by Western blot as well. Results The BMSCs were cultured successfully. The expression of VEGF protein was higher in AdCMV-VEGF-BMSCs than that in groups of BMSCs and AdCMV-eGFP-BMSCs. Conclusion The rat BMSCs have been successfully cultured and transfected by AdCMV-VEGF, which may provide an useful reference in the treatment of cerebral vascular disease.
出处 《江苏医药》 CAS 北大核心 2014年第4期381-384,F0002,共5页 Jiangsu Medical Journal
关键词 腺病毒 血管内皮生长因子 骨髓间充质干细胞 Adenovirus Vascular endothelial growth factor Bone marrow mesenchymal stem ceils
  • 相关文献

参考文献18

  • 1Kaneko Y,Tajiri N,Shinozuka K. Cell therapy for stroke:emphasis on optimizing safety and efficacy profile of endothelial progenitor cells[J].{H}Current Pharmaceutical Design,2012,(25):3731-3734.
  • 2Towfighi A,Ovbiagele B,Save JL. Therapeutic milestone:stroke declines from the second to the third leading organ-and disease-specific cause of death in the united states[J].{H}STROKE,2010,(03):499-503.
  • 3DharmasarojaP. Bone marrow-derived mesenchymal stem cells for the treatment of ischemic stroke[J].{H}Journal of Clinical Neuroscience,2009,(01):12-20.
  • 4Jung DI,Ha J,Kang BT. A comparison of autologous and allogenic bone marrow-delved mesenchymal stem cell transplantation in canine spinal cord injury[J].{H}Journal of the Neurological Sciences,2009,(1-2):67-77.
  • 5Van Damme A,Vanden Driessche T,Collen D. Bone marrow stromal cells as targets for gene therapy[J].{H}CURRENT GENE THERAPY,2002,(02):195-209.
  • 6Graham GD. Tissue plasminogen activator for acute ischemic stroke in clinical practice:a meta-analysis of safety data[J].{H}STROKE,2003,(12):2847-2850.
  • 7Yip TR,Demaerschalk BM. Estimated cost savings of increased use of intravenous tissue plasminogen activator for acute ischemic stroke in canada[J].{H}STROKE,2007,(06):1952-1955.
  • 8Bosnakovski D,Mizuno M,Kim G. Isolation and multiline age differentiation of bovine bone marrow mesenchymal stem cells[J].{H}Cell and Tissue Research,2005,(02):243-253.
  • 9Lee KD,Kuo TK,Whang-Peng J. In vitro hepatic differentiation of human mesenchymal stem cells[J].{H}HEPATOLOGY,2004,(06):1275-1284.
  • 10Arthut A,Zannettino A,Gronthos S. The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair[J].{H}Journal of Cellular Physiology,2009,(02):237-245.

二级参考文献1

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部